Law Journal Newsletters

An ALM Website

MEDICAL MALPRACTICE LAW & STRATEGY

January 2013

Drug Marketing to Doctors: Changes May Be On the Way

By Janice G. Inman

The cornerstone of many FDA enforcement actions against pharmaceuticals manufacturers in recent years has been the charge that they have "misbranded" their pharmaceutical products by promoting them for uses not approved by the FDA. Now, the Second Circuit has thrown the concept of criminal liability for misbranding by means of off-label-use promotion into turmoil.

Log In

Subscribers: Log in below to read the full story

Already subscribe but haven't registered for all the benefits of the website?

Subscribe

Click below to subscribe to
MEDICAL MALPRACTICE LAW & STRATEGY

Subscribe

Pay-Per-View

You can purchase this article for $20.00
Click below

Purchase Article

ARTICLES FROM RELATED NEWSLETTERS

BUSINESS CRIMES BULLETIN

Keeping Government Environmental Investigations Civil

The threat of criminal environmental prosecutions is real. Most federal and state environmental statutes provide for criminal prosecution in appropriate circumstances, often for knowing violations of environmental law, but sometimes even on a negligence or strict liability basis. Here's what you need to know.

THE CORPORATE COUNSELOR

Quarterly State Compliance Review

This edition of the Quarterly State Compliance Review looks at some legislation of interest to corporate lawyers that went into effect between Jan. 1, 2015 and April 1, 2015. It also looks at some recent decisions of interest from the courts of Delaware, Georgia and Maryland.

THE CORPORATE COUNSELOR

Defining the Intersection of Legal and GRC

While the convergence of legal management and enterprise governance, risk, and compliance (GRC) is not new, more recent efforts to manage this development through integrated technology are fast becoming a strategic imperative.